Successful treatment of rhinocerebral mucormycosis with liposomal amphotericin B and surgery in two diabetic patients with renal dysfunction

Journal of Chemotherapy

Volumn 15, Issue 3, 2003, Pages 282-286

  Kofteridis, D P ^a,b   Karabekios, S ^a   Panagiotides, J G ^a   Bizakis, J ^a   Kyrmizakis, D ^a   Saridaki, Z ^a   Gikas, A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

Amphotericin B; Diabetes mellitus; Rhinocerebral mucormycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; BUDESONIDE; GLICLAZIDE; STEROID;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG FORMULATION; ETHMOIDECTOMY; FUNGUS CULTURE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MALE; MUCORMYCOSIS; NASAL BIOPSY; PHYCOMYCETES; PHYSICAL EXAMINATION; RHINOCEREBRAL MUCORMYCOSIS; TREATMENT OUTCOME; ZYGOMYCETES;

EID: 0038345546     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.3.282     Document Type: Article

References (20)

1. Sugar M Alan. Agents of mucormycosis and related species. In: Mandell GL., Douglas R.G & Bennet JE, eds. Principles and Practice of Infectious Diseases, fifth edition. Churchill Livingston, New York. 2000; 2685-95.
2. McNaulty JS. Rhinocerebral mucormycosis: Predisposing factors. Laryngoscope 1982; 92:1140
3. Kontogiannis DP, Wessel VC, Bodey GP, Rolston VI. Zygomycosis in a terziary-care cancer center. Clin Infect Dis 2000; 30: 851-6.
4. Dismukes W E. Introduction to antifungal drugs. Clin Infect Dis 2000; 30: 653-7.
5. Moses A, Rhav G, Barenholz Y, et al. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients. Clin Infect Dis 1998; 26: 1430-3.
6. Finn DG, Farmer JC Jr. Chronic mucormycosis. Laryngoscope 1982; 92: 761-63.
7. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 1999; 340: 764-71.
8. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: Clinical efficacy and toxicities. Clin Infect Dis 1998; 27: 603-18.
9. Wingard JR, White MH, Anaissie E, Raffaelli J, Goodman J, Arrieta A, and the L Amph / ABLC collaborative study group. A randomized, double - blind comparative trail evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. Clin Infect Dis 2000; 31: 1155-63.
10. Rangel-Guerra RA, Martinez HR, Saenz C, Bosques-Padilla F, Estrada-Bellman I. Rhinocerebral and systemic mucormycosis: clinical experience with 36 patients. J Neurol Sci 1996;143: 19-30.
11. Case record of the Massachusetts General Hospital. Case 22-1999. N Engl J Med 1999; 341 (4): 265-73.
12. Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ: Mucormycosis. Annals of Internal Medicine. 1980; 93: 93-108.
13. Herbrecht R, Letscher-Bru V, Bowden RA, et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001; 20: 460-66.
14. Raj P, Vella EJ, Bickerton RC. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomoal amphotericin B and local therapy with nebulized amphotericin - a case report. J Laryngol Otol 1998; 112: 367-70.
15. Tsaousis G, Koutsouri A, Gatsiou C, Paniara O, Peppas C, Chalevelakis G. Liver and brain mucormycosis in a diabetic patient type II successfully treated with liposomal amphotericin B. Scand J Infect Dis 2000; 32 (3): 335-37.
16. Mondy KE, Haughey B, Custer PL, Wippold II FJ, Ritchie DJ, Mundy LM. Rhinocerebral mucormycosis in the era of lipid-based Amphotericin B: case report and literature review. Pharmacotherapy 2002, 22(4): 519-526.
17. Sohail MA, Al Khabori M, Hyder J, Verma A. Acute fulminant fungal sinusitis: clinical presentation, radiological findings and treatment Acta Tropica, 2001; 80 (2): 177-85.
18. Ruoppi P, Dietz A, Nikanne E, Seppä J, Markkanen H, Nuutinen J. Paranasal sinus mucormycosis: a report of two cases. Acta Oto-Laryngologica 2001; 121 (8): 948-52.
19. Cagatay AA, Oncu SS, Calangu SS, Yildirmak TT, Ozsut HH, Eraksoy HH. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report. BMC Infect Dis 2001; 1 (1): 22.
20. Cagnoni JP, Walsh TJ, Prendergast MM, et al. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. J Clin Oncol 2000;18 (12): 2476-83.